Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH)
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study (NCT07336563) | Jarosław Drobnik | 2026-01-05 |
| A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis) (NCT06318169) | 89bio, Inc. | 2024-03-13 |
Track Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) automatically
Every clearance here is in the API, with alerts when new ones post.